Group’s record 2025 results set the stage for a pivotal year ahead, as the pan-Asian life insurer bets on AI, expansion across China’s provinces, and deepening wealth partnerships.
The W&I product expansion looks to address both historical and future risks with "predictable cost structure" for cyber, environmental, D&O, and crisis management add-on covers.
The Shield MCD test screens for 10 of the most common cancers — bladder, colorectal, breast, prostate, esophageal, gastric, liver, lung, ovarian, and pancreatic — with just a blood draw.
Bruce Ford, Goh Thian Leong, Mark Foster, and Florence Lam Puoy Yin have joined the reinsurance broker as part of its strategic treaty expansion in Asia.
Zurich's cross-border collaboration backs Guinness World Record holder Natalie Dau's "Breaking 8" challenge, channelling funds toward displaced families and marginalised children across Southeast Asia...
